Can Platelet-Rich Plasma Enhance Tendon Repair?
Background: Autologous platelet-rich plasma (PRP) application appears to improve tendon healing in traumatic tendon injuries, but basic knowledge of how PRP promotes tendon repair is needed. Hypothesis: Platelet-rich plasma has a positive effect on cell proliferation and collagen production and indu...
Gespeichert in:
Veröffentlicht in: | The American journal of sports medicine 2008-06, Vol.36 (6), p.1171 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Autologous platelet-rich plasma (PRP) application appears to improve tendon healing in traumatic tendon injuries, but basic
knowledge of how PRP promotes tendon repair is needed.
Hypothesis: Platelet-rich plasma has a positive effect on cell proliferation and collagen production and induces the production of matrix-degrading
enzymes and endogenous growth factors by human tenocytes.
Study Design: Controlled laboratory study.
Methods: Human tenocytes were cultured 14 days in 2% fetal calf serum medium complemented with 0%, 10%, or 20% vol/vol platelet-rich
clot releasate ([PRCR] the active releasate of PRP) or platelet-poor clot releasate (PPCR). At day 4, 7, and 14, cell amount,
total collagen, and gene expression of collagen Iα1 (COL1) and IIIα1 (COL3), matrix metalloproteinases ([MMPs] MMP1, MMP3,
and MMP13), vascular endothelial-derived growth factor (VEGF)-A, and transforming growth factor (TGF)-β1 were analyzed.
Results: Platelet numbers in PRP increased to 2.55 times baseline. Growth-factor concentrations of VEGF and platelet-derived growth
factor (PDGF)-BB were higher in PRCR than PPCR. Both PRCR and PPCR increased cell number and total collagen, whereas they
decreased gene expression of COL1 and COL3 without affecting the COL3/COL1 ratio. PRCR, but not PPCR, showed upregulation
of MMP1 and MMP3 expression. Matrix metalloproteinase 13 expression was not altered by either treatment. PRCR increased VEGF-A
expression at all time points and TGF-β1 expression at day 4.
Conclusion: In human tenocyte cultures, PRCR, but also PPCR, stimulates cell proliferation and total collagen production. PRCR, but not
PPCR, slightly increases the expression of matrix-degrading enzymes and endogenous growth factors.
Clinical Relevance: In vivo use of PRP, but also of PPP to a certain extent, in tendon injuries might accelerate the catabolic demarcation of
traumatically injured tendon matrices and promote angiogenesis and formation of a fibrovascular callus. Whether this will
also be beneficial for degenerative tendinopathies remains to be elucidated.
Keywords:
platelet-rich plasma
tendon
growth factors
collagen
matrix metalloproteinases |
---|---|
ISSN: | 0363-5465 1552-3365 |
DOI: | 10.1177/0363546508314430 |